Kirin Holdings’ LC-Plasma paraprobiotic reduces dengue fever symptoms in clinical trial

Related Articles

FormattedPicture

BUSINESS NEWS

Ahead of an over US$8 million investment in a production facility, Kirin Holdings is unveiling food products containing Lactococcus lactis strain Plasma to target... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Kirin Beverage Company will launch two immunity beverages in Japan in October. The company asserts the new products are the nation’s first black tea and green tea... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

UK-based Performance Labs is unveiling a probiotic immunity support supplement branded PL-Immune. The product contains key Kyowa Hakko ingredients Immuse and Setria... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Giellepi Health Science has created a patented, clinically verified paraprobiotic that enhances adults’ immune system activities without traditional... Read More

FormattedPicture

FOOD RESEARCH

A study from the Kirin Central Research Institute has demonstrated that milk-derived beta-lactopeptides improve cerebral blood flow (CBF) in the prefrontal cortex, which... Read More

trans